Correlation Between Sumitomo Mitsui and X4 Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sumitomo Mitsui and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Mitsui and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sumitomo Mitsui Financial and X4 Pharmaceuticals, you can compare the effects of market volatilities on Sumitomo Mitsui and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Mitsui with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Mitsui and X4 Pharmaceuticals.

Diversification Opportunities for Sumitomo Mitsui and X4 Pharmaceuticals

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sumitomo and XFOR is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Mitsui Financial and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Sumitomo Mitsui is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Mitsui Financial are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Sumitomo Mitsui i.e., Sumitomo Mitsui and X4 Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sumitomo Mitsui and X4 Pharmaceuticals

Assuming the 90 days horizon Sumitomo Mitsui Financial is expected to generate 0.46 times more return on investment than X4 Pharmaceuticals. However, Sumitomo Mitsui Financial is 2.16 times less risky than X4 Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest  1,529  in Sumitomo Mitsui Financial on June 12, 2025 and sell it today you would earn a total of  1,269  from holding Sumitomo Mitsui Financial or generate 83.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.89%
ValuesDaily Returns

Sumitomo Mitsui Financial  vs.  X4 Pharmaceuticals

 Performance 
       Timeline  
Sumitomo Mitsui Financial 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sumitomo Mitsui Financial are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Sumitomo Mitsui reported solid returns over the last few months and may actually be approaching a breakup point.
X4 Pharmaceuticals 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Sumitomo Mitsui and X4 Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sumitomo Mitsui and X4 Pharmaceuticals

The main advantage of trading using opposite Sumitomo Mitsui and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Mitsui position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.
The idea behind Sumitomo Mitsui Financial and X4 Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Managers
Screen money managers from public funds and ETFs managed around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance